| 1.87 Data as of 3:59pm ET |  -0.03 / -1.58%Today’s Change | 1.70 Today|||52-Week Range 5.63 | -21.43% Year-to-Date |
| Previous close | 1.90 |
| Today’s open | 1.85 |
| Day’s range | 1.85 - 1.90 |
| Volume | 172,930 |
| Average volume (3 months) | 245,411 |
| Market cap | $48.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +40.80% |
| Earnings growth (this year) | +41.05% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -6.62% |
| P/E ratio | -- |
| Price/Sales | 1.40 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| ENMDEntreMed Inc | -0.03 | -1.49% |
| ARWRArrowhead Research C... | +0.01 | +0.50% |
| BCLIBrainstorm Cell Ther... | +0.01 | +3.41% |
| STEMStemCells Inc | -0.09 | -5.08% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $33.7M |
| Annual profit (last year) | -$20.4M |
| Net profit margin | -60.63% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director David A. Dodd |
Chief Financial Officer & Senior Vice President Dennis Turpin, CPA |
Corporate headquarters Québec, Québec |
.
